NO993658D0 - Sulfonylurea-derivater - Google Patents

Sulfonylurea-derivater

Info

Publication number: NO993658D0
Authority: NO; Norway
Prior art keywords: sulfonylurea derivatives; sulfonylurea; derivatives
Prior art date: 1997-01-29

Application number

NO993658A

Other languages

English (en)

Other versions

NO313279B1 (no

NO993658L (no

Inventor

Mark Anthony Dombroski

James Frederick Eggler

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-29

Filing date

1999-07-28

Publication date

1999-07-28

1999-07-28 Application filed by Pfizer filed Critical Pfizer

1999-07-28 Publication of NO993658D0 publication Critical patent/NO993658D0/no

1999-09-28 Publication of NO993658L publication Critical patent/NO993658L/no

2002-09-09 Publication of NO313279B1 publication Critical patent/NO313279B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Indole Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

NO19993658A 1997-01-29 1999-07-28 Sulfonylurea-derivater, anvendelse derav samt farmasöytisk blanding NO313279B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3697997P	1997-01-29	1997-01-29
PCT/IB1997/001603 WO1998032733A1 (en)	1997-01-29	1997-12-29	Sulfonyl urea derivatives and their use in the control of interleukin-1 activity

Publications (3)

Publication Number	Publication Date
NO993658D0 true NO993658D0 (no)	1999-07-28
NO993658L NO993658L (no)	1999-09-28
NO313279B1 NO313279B1 (no)	2002-09-09

Family

ID=21891776

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19993658A NO313279B1 (no)	1997-01-29	1999-07-28	Sulfonylurea-derivater, anvendelse derav samt farmasöytisk blanding

Country Status (40)

Country	Link
US (2)	US6166064A (no)
EP (1)	EP0964849B1 (no)
JP (1)	JP3573757B2 (no)
KR (1)	KR100324058B1 (no)
CN (1)	CN1127479C (no)
AP (1)	AP929A (no)
AR (1)	AR011093A1 (no)
AT (2)	ATE242208T1 (no)
AU (1)	AU723895B2 (no)
BG (1)	BG103597A (no)
BR (1)	BR9714328A (no)
CA (1)	CA2279186C (no)
CO (1)	CO4920230A1 (no)
CZ (1)	CZ293173B6 (no)
DE (2)	DE69729762T2 (no)
DK (2)	DK0964849T3 (no)
DZ (1)	DZ2407A1 (no)
EA (1)	EA001803B1 (no)
ES (2)	ES2222426T3 (no)
HR (1)	HRP980045B1 (no)
HU (1)	HUP0000567A3 (no)
ID (1)	ID22223A (no)
IL (1)	IL130855A0 (no)
IS (1)	IS5099A (no)
MA (1)	MA26468A1 (no)
NO (1)	NO313279B1 (no)
NZ (1)	NZ336248A (no)
OA (1)	OA11079A (no)
PA (1)	PA8444701A1 (no)
PE (1)	PE57898A1 (no)
PL (1)	PL335052A1 (no)
PT (2)	PT964849E (no)
SK (1)	SK283679B6 (no)
TN (1)	TNSN98017A1 (no)
TR (1)	TR199901816T2 (no)
TW (1)	TW515788B (no)
UY (1)	UY24861A1 (no)
WO (1)	WO1998032733A1 (no)
YU (1)	YU33799A (no)
ZA (1)	ZA98685B (no)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6022984A (en) *	1998-07-27	2000-02-08	Pfizer Inc.	Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors
EP1526383A3 (en) *	1998-08-31	2005-11-16	Pfizer Products Inc.	Diarylsulfonylurea binding proteins
IT1303249B1 (it) *	1998-10-23	2000-11-06	Dompe Spa	Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
WO2001019390A1 (en) *	1999-09-14	2001-03-22	Pfizer Products Inc.	Combination treatment with il-1ra and diaryl sulphonyl urea compounds
US6808902B1 (en)	1999-11-12	2004-10-26	Amgen Inc.	Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
CA2369967A1 (en) *	2001-02-12	2002-08-12	Joseph Anthony Cornicelli	Methods of treating nuclear factor-kappa b mediated diseases and disorders
JP4212470B2 (ja)	2001-06-26	2009-01-21	アムジェンフレモントインク．	Ｏｐｇｌへの抗体
CA2459454A1 (en)	2001-09-14	2003-03-27	Bayer Pharmaceuticals Corporation	Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
AU2002341321A1 (en) *	2001-11-30	2003-06-10	Pfizer Products Inc.	Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
US20030131370A1 (en) *	2001-12-14	2003-07-10	Pfizer Inc.	Disruption of the glutathione S-transferase-Omega-1 gene
RU2236677C2 (ru) *	2002-06-24	2004-09-20	Чичкова Марина Александровна	Способ прогнозирования раннего клинического течения экссудативного перикардита у больных с системными заболеваниями
AU2003245989A1 (en)	2002-07-09	2004-01-23	Boehringer Ingelheim Pharma Gmbh And Co. Kg	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
KR101317045B1 (ko)	2002-09-06	2013-10-16	암젠 인코포레이티드	치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체
AU2003263560A1 (en) *	2002-10-03	2004-04-23	Pfizer Products Inc.	Use of gst-omega-2 as a therapeutic target
EP3431464A3 (en)	2003-08-06	2019-07-31	Senomyx Inc.	Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
PT1776336E (pt) *	2004-03-23	2009-12-18	Dompe Spa	Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm
US20060045953A1 (en) *	2004-08-06	2006-03-02	Catherine Tachdjian	Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
CN101384183B (zh)	2005-02-04	2012-07-04	西诺米克斯公司	包含连接有杂芳基部分的化合物及其作为用于食物组合物的新型鲜味调节剂、促味剂和味觉增强剂的应用
WO2006090921A1 (ja) *	2005-02-28	2006-08-31	Eisai R & D Management Co., Ltd.	スルホンアミド化合物のリンパ球活性化抑制作用
US7208526B2 (en) *	2005-05-20	2007-04-24	Hoffmann-La Roche Inc.	Styrylsulfonamides
AR055329A1 (es)	2005-06-15	2007-08-15	Senomyx Inc	Amidas bis-aromaticas y sus usos como modificadores de sabor dulce, saborizantes, y realzadores de sabor
US8148536B2 (en)	2006-04-21	2012-04-03	Senomyx, Inc.	Comestible compositions comprising high potency savory flavorants, and processes for producing them
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US7973051B2 (en) *	2007-11-30	2011-07-05	Hoffman-La Roche Inc.	Aminothiazoles as FBPase inhibitors for diabetes
HK1215170A1 (zh)	2012-11-14	2016-08-19	The Johns Hopkins University	治療精神分裂症的方法和組合物
CA2957566C (en)	2014-08-12	2023-08-01	Daniel Paul Becker	Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same
SI3578547T1 (sl) *	2015-02-16	2021-09-30	The University Of Queensland	Sulfonilsečnine in sorodne spojine ter njihova uporaba
WO2016138473A1 (en) *	2015-02-26	2016-09-01	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inflammasome activation in myelodysplastic syndromes
FR3046933B1 (fr)	2016-01-25	2018-03-02	Galderma Research & Development	Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
WO2017140778A1 (en) *	2016-02-16	2017-08-24	The University Of Queensland	Sulfonylureas and related compounds and use of same
EP3445756B1 (en) *	2016-04-18	2022-07-06	Novartis AG	Compounds and compositions for treating conditions associated with nlrp activity
MA44734A (fr) *	2016-04-18	2021-05-19	Novartis Ag	Composés et compositions destinés au traitement d'états associés à une activité de nlrp
EP3272739A1 (en) *	2016-07-20	2018-01-24	NodThera Limited	Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
WO2018102419A1 (en) *	2016-11-29	2018-06-07	Epizyme, Inc.	Compounds containing a sulfonic group as kat inhibitors
MA55695A (fr)	2017-01-23	2022-02-23	Genentech Inc	Composés chimiques comme inhibiteurs de l'activité interleukine-1
US11840543B2 (en)	2017-05-24	2023-12-12	The University Of Queensland	Compounds and uses
US11236045B2 (en)	2017-06-09	2022-02-01	Cadila Healthcare Limited	Substituted sulfoximine compounds
CA3067410A1 (en)	2017-07-07	2019-01-10	Inflazome Limited	Novel sulfonamide carboxamide compounds
WO2019008029A1 (en)	2017-07-07	2019-01-10	Inflazome Limited	SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
PL3658539T3 (pl)	2017-07-24	2024-07-01	Novartis Ag	Związki i kompozycje do leczenia stanów związanych z aktywnością nlrp
MA49904A (fr)	2017-08-15	2020-06-24	Inflazome Ltd	Nouveaux composés de sulfonamide carboxamide
WO2019034692A1 (en)	2017-08-15	2019-02-21	Inflazome Limited	SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
WO2019034693A1 (en)	2017-08-15	2019-02-21	Inflazome Limited	SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
WO2019034697A1 (en)	2017-08-15	2019-02-21	Inflazome Limited	NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
UY37847A (es)	2017-08-15	2019-03-29	Inflazome Ltd	Sulfonilureas y sulfoniltioureas útiles como inhibidores de nlrp3
WO2019043610A1 (en)	2017-08-31	2019-03-07	Cadila Healthcare Limited	NEW SUBSTITUTED SULFONYLUREA DERIVATIVES
WO2019068772A1 (en)	2017-10-03	2019-04-11	Inflazome Limited	NEW COMPOUNDS
US11718631B2 (en)	2017-10-17	2023-08-08	Novartis Ag	Sulphonamides and compositions thereof for treating conditions associated with NLRP activity
BR112020008981A2 (pt)	2017-11-09	2020-11-17	Inflazome Limited	novos compostos de sulfonamida carboxamida
EP3707137A1 (en)	2017-11-09	2020-09-16	Inflazome Limited	Novel sulfonamide carboxamide compounds
GB201721185D0 (en)	2017-12-18	2018-01-31	Nodthera Ltd	Sulphonyl urea derivatives
CN108299256B (zh) *	2018-01-09	2019-09-10	武汉大学	一类2,3,4-三羟基苯磺酰胺衍生物及其制备方法和应用
WO2019166629A1 (en)	2018-03-02	2019-09-06	Inflazome Limited	Novel compounds
EP3759078A1 (en)	2018-03-02	2021-01-06	Inflazome Limited	Novel compounds
EP3759077A1 (en)	2018-03-02	2021-01-06	Inflazome Limited	Novel compounds
US11834433B2 (en)	2018-03-02	2023-12-05	Inflazome Limited	Compounds
EP3759073A1 (en)	2018-03-02	2021-01-06	Inflazome Limited	Sulfonamide derivates as nlrp3 inhibitors
EP3759103A1 (en)	2018-03-02	2021-01-06	Inflazome Limited	Novel compounds
CN112584899A (zh) *	2018-07-03	2021-03-30	诺华股份有限公司	Nlrp调节剂
MA53172A (fr)	2018-07-20	2021-05-26	Hoffmann La Roche	Composés de sulfonimidamide en tant qu'inhibiteurs de l'activité de l'interleukine 1
EP3823726A1 (en)	2018-07-20	2021-05-26	F. Hoffmann-La Roche SA	Sulfonylurea compounds as inhibitors of interleukin-1 activity
WO2020035482A1 (en)	2018-08-13	2020-02-20	Iltoo Pharma	Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
SG11202101480XA (en)	2018-08-15	2021-03-30	Inflazome Ltd	Novel sulfonamideurea compounds
JP2022505525A (ja) *	2018-10-24	2022-01-14	ノバルティスアーゲー	Ｎｌｒｐ活性に関連する状態を治療するための化合物及び組成物
SG11202107680PA (en)	2019-01-14	2021-08-30	Cadila Healthcare Ltd	Novel substituted sulfonylurea derivatives
PL3983387T3 (pl)	2019-06-12	2024-08-19	NodThera Limited	Pochodne sulfonylomocznika i ich zastosowania
US20220378801A1 (en)	2019-06-21	2022-12-01	Ac Immune Sa	Novel compounds
CN114746087A (zh) *	2019-09-12	2022-07-12	载度思生命科学有限公司	新的经取代的亚砜亚胺衍生物
WO2021249337A1 (zh) *	2020-06-11	2021-12-16	南京明德新药研发有限公司	二甲基亚磺酰亚胺衍生物
AU2021291065B2 (en)	2020-06-19	2025-06-26	Ac Immune Sa	Dihydrooxazole and thiourea or urea derivatives modulating the nlrp3 inflammasome pathway
WO2022022646A1 (zh) *	2020-07-29	2022-02-03	南京明德新药研发有限公司	含硒五元杂芳环化合物
KR20230061505A (ko)	2020-09-04	2023-05-08	노드테라 리미티드	알킬-옥사사이클로알킬 모이어티를 함유하는 설파모일 우레아 유도체 및 이의 용도
ES2948511A1 (es) *	2021-09-08	2023-09-13	Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa	Derivados de n-sulfonilureas y su uso terapeutico
WO2023098612A1 (zh) *	2021-12-03	2023-06-08	南京明德新药研发有限公司	二甲基亚磺酰亚胺衍生物的盐型及晶型
WO2023118521A1 (en)	2021-12-22	2023-06-29	Ac Immune Sa	Dihydro-oxazol derivative compounds
AU2023220628A1 (en) *	2022-02-15	2024-05-23	F. Hoffmann-La Roche Ag	Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivatives
US20250283174A1 (en)	2022-05-16	2025-09-11	Institut National de la Santé et de la Recherche Médicale	Methods for assessing the exhaustion of hematopoietic stem cells induced by chronic inflammation
US20240034735A1 (en)	2022-07-14	2024-02-01	Ac Immune Sa	Novel compounds
AU2023313032A1 (en)	2022-07-28	2025-01-23	Ac Immune Sa	Novel compounds
WO2025133307A1 (en)	2023-12-22	2025-06-26	Ac Immune Sa	Heterocyclic modulators of the nlrp3 inflammasome pathway
WO2025153532A1 (en)	2024-01-16	2025-07-24	NodThera Limited	Nlrp3 inhibitors and glp-1 agonists combination therapies
WO2025153625A1 (en)	2024-01-17	2025-07-24	Ac Immune Sa	Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway
WO2025153624A1 (en)	2024-01-17	2025-07-24	Ac Immune Sa	Imidazo[1,2-d][1,2,4]triazine derivatives for use as inhibitors of the nlrp3 inflammasome pathway
WO2025163069A1 (en)	2024-01-31	2025-08-07	Ac Immune Sa	Novel compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4586950A (en) *	1982-05-31	1986-05-06	E. I. Du Pont De Nemours & Company	Novel phenyl-substituted sulfonamides
US4780125A (en) *	1982-09-01	1988-10-25	Ciba-Geigy Corporation	N-phenylsulfonyl-N'-triazinylureas
DE3927369A1 (de) *	1989-08-19	1991-02-21	Bayer Ag	Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
US5064851A (en) *	1990-07-24	1991-11-12	Pfizer Inc.	3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
US5254589A (en) *	1991-10-15	1993-10-19	Warner-Lambert Company	Sulfonyl urea and carbamate ACAT inhibitors
DE4344957A1 (de) *	1993-12-30	1995-07-06	Hoechst Ag	Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Herstellungsverfahren und Verwendungsmöglichkeiten pharmazeutischer Präparate auf Basis dieser Verbindungen
CN1038679C (zh) *	1994-12-07	1998-06-10	南开大学	磺酰脲类化合物及其除草用途
HU226462B1 (en) *	1995-02-17	2008-12-29	Hoechst Ag	Substituted benzol-sulfonyl-ureas and -thioureas, process for producing them, pharmaceutical compositions containing them, and their use
US6281240B1 (en) *	1997-04-10	2001-08-28	Eli Lilly And Company	Diarylsulfonylureas for use in treating secretory diarrhea

1997
- 1997-12-29 PT PT97947201T patent/PT964849E/pt unknown
- 1997-12-29 DK DK97947201T patent/DK0964849T3/da active
- 1997-12-29 SK SK982-99A patent/SK283679B6/sk unknown
- 1997-12-29 BR BR9714328A patent/BR9714328A/pt not_active Application Discontinuation
- 1997-12-29 IL IL13085597A patent/IL130855A0/xx unknown
- 1997-12-29 YU YU33799A patent/YU33799A/sh unknown
- 1997-12-29 AT AT97947201T patent/ATE242208T1/de not_active IP Right Cessation
- 1997-12-29 JP JP51868798A patent/JP3573757B2/ja not_active Expired - Fee Related
- 1997-12-29 EP EP97947201A patent/EP0964849B1/en not_active Expired - Lifetime
- 1997-12-29 AT AT02020749T patent/ATE270285T1/de not_active IP Right Cessation
- 1997-12-29 CA CA002279186A patent/CA2279186C/en not_active Expired - Fee Related
- 1997-12-29 ES ES02020749T patent/ES2222426T3/es not_active Expired - Lifetime
- 1997-12-29 DE DE69729762T patent/DE69729762T2/de not_active Expired - Fee Related
- 1997-12-29 CN CN97181579A patent/CN1127479C/zh not_active Expired - Fee Related
- 1997-12-29 NZ NZ336248A patent/NZ336248A/xx unknown
- 1997-12-29 PL PL97335052A patent/PL335052A1/xx unknown
- 1997-12-29 HU HU0000567A patent/HUP0000567A3/hu unknown
- 1997-12-29 DE DE69722663T patent/DE69722663T2/de not_active Expired - Fee Related
- 1997-12-29 DK DK02020749T patent/DK1270565T3/da active
- 1997-12-29 PT PT02020749T patent/PT1270565E/pt unknown
- 1997-12-29 ES ES97947201T patent/ES2198598T3/es not_active Expired - Lifetime
- 1997-12-29 WO PCT/IB1997/001603 patent/WO1998032733A1/en not_active Ceased
- 1997-12-29 TR TR1999/01816T patent/TR199901816T2/xx unknown
- 1997-12-29 ID IDW990764A patent/ID22223A/id unknown
- 1997-12-29 EA EA199900603A patent/EA001803B1/ru not_active IP Right Cessation
- 1997-12-29 AU AU52340/98A patent/AU723895B2/en not_active Ceased
- 1997-12-29 KR KR1019997006786A patent/KR100324058B1/ko not_active Expired - Fee Related
- 1997-12-29 US US09/341,782 patent/US6166064A/en not_active Expired - Fee Related
- 1997-12-29 CZ CZ19992575A patent/CZ293173B6/cs not_active IP Right Cessation
1998
- 1998-01-16 PA PA19988444701A patent/PA8444701A1/es unknown
- 1998-01-20 UY UY24861A patent/UY24861A1/es unknown
- 1998-01-23 PE PE1998000051A patent/PE57898A1/es not_active Application Discontinuation
- 1998-01-26 TW TW087101087A patent/TW515788B/zh not_active IP Right Cessation
- 1998-01-27 AR ARP980100358A patent/AR011093A1/es not_active Application Discontinuation
- 1998-01-27 HR HR980045A patent/HRP980045B1/xx not_active IP Right Cessation
- 1998-01-27 DZ DZ980017A patent/DZ2407A1/xx active
- 1998-01-28 MA MA24947A patent/MA26468A1/fr unknown
- 1998-01-28 ZA ZA9800685A patent/ZA98685B/xx unknown
- 1998-01-28 TN TNTNSN98017A patent/TNSN98017A1/fr unknown
- 1998-01-29 CO CO98004326A patent/CO4920230A1/es unknown
- 1998-01-29 AP APAP/P/1998/001190A patent/AP929A/en active
1999
- 1999-06-29 IS IS5099A patent/IS5099A/is unknown
- 1999-07-22 BG BG103597A patent/BG103597A/bg unknown
- 1999-07-23 OA OA9900165A patent/OA11079A/en unknown
- 1999-07-28 NO NO19993658A patent/NO313279B1/no not_active IP Right Cessation
2000
- 2000-10-31 US US09/703,142 patent/US6433009B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2279186C (en)	2004-02-24
PL335052A1 (en)	2000-03-27
CZ257599A3 (cs)	2000-09-13
BG103597A (bg)	2000-02-29
NO313279B1 (no)	2002-09-09
WO1998032733A1 (en)	1998-07-30
DE69729762D1 (de)	2004-08-05
HUP0000567A2 (hu)	2000-10-28
DE69722663D1 (de)	2003-07-10
CO4920230A1 (es)	2000-05-29
CN1245490A (zh)	2000-02-23
TR199901816T2 (xx)	1999-11-22
PT1270565E (pt)	2004-09-30
IL130855A0 (en)	2001-01-28
NO993658L (no)	1999-09-28
KR20000070541A (ko)	2000-11-25
DK0964849T3 (da)	2003-08-25
EP0964849A1 (en)	1999-12-22
TNSN98017A1 (fr)	2005-03-15
SK98299A3 (en)	2001-10-08
ID22223A (id)	1999-09-16
MA26468A1 (fr)	2004-12-20
DZ2407A1 (fr)	2003-01-04
EA199900603A1 (ru)	2000-02-28
PE57898A1 (es)	1999-06-11
AP929A (en)	2001-01-18
CA2279186A1 (en)	1998-07-30
JP3573757B2 (ja)	2004-10-06
OA11079A (en)	2002-03-14
HRP980045B1 (en)	2002-10-31
DE69729762T2 (de)	2005-07-14
ES2198598T3 (es)	2004-02-01
BR9714328A (pt)	2000-03-21
KR100324058B1 (ko)	2002-02-16
ES2222426T3 (es)	2005-02-01
HUP0000567A3 (en)	2002-10-28
US6433009B1 (en)	2002-08-13
PA8444701A1 (es)	2000-05-24
NZ336248A (en)	2000-10-27
SK283679B6 (sk)	2003-11-04
EP0964849B1 (en)	2003-06-04
ATE242208T1 (de)	2003-06-15
ZA98685B (en)	1999-07-29
ATE270285T1 (de)	2004-07-15
US6166064A (en)	2000-12-26
DE69722663T2 (de)	2004-04-29
JP2000511200A (ja)	2000-08-29
EA001803B1 (ru)	2001-08-27
PT964849E (pt)	2003-08-29
TW515788B (en)	2003-01-01
IS5099A (is)	1999-06-29
HRP980045A2 (en)	1999-06-30
UY24861A1 (es)	2000-09-29
AU723895B2 (en)	2000-09-07
CN1127479C (zh)	2003-11-12
DK1270565T3 (da)	2004-10-04
CZ293173B6 (cs)	2004-02-18
AR011093A1 (es)	2000-08-02
AU5234098A (en)	1998-08-18
AP9801190A0 (en)	1998-03-31
YU33799A (sh)	2002-03-18

Publication	Publication Date	Title
NO993658L (no)	1999-09-28	Sulfonylurea-derivater
ATE284385T1 (de)	2004-12-15	Sulfonamidderivate
DK1005446T3 (da)	2004-06-07	N-aroylphenylalaninderivater
ATE235220T1 (de)	2003-04-15	Resorcinderivate
ID22781A (id)	1999-12-09	Turunan-turunan nikotinamida
DE69817186D1 (de)	2003-09-18	Diaminorhodamin-derivate
DK0973746T3 (da)	2004-02-02	Substituerede 3-cyanoquinoliner
PT915088E (pt)	2003-01-31	Derivados de d-prolina
ATE255098T1 (de)	2003-12-15	Substituierte chromanderivate
PT1003719E (pt)	2002-10-31	Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
ATE440854T1 (de)	2009-09-15	5-deoxy-cytidin-derivate
PT1027362E (pt)	2005-08-31	Derivados de cetolidos 2-halogeno-6-o-substituidos
ATE255099T1 (de)	2003-12-15	Substituierte chromanderivate
DE59813487D1 (de)	2006-05-24	Substituierte 4-benzoyl-pyrazole
DK0966437T3 (da)	2002-10-07	5-Aroylnaphthalenderivater
ATE292632T1 (de)	2005-04-15	Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69828780D1 (de)	2005-03-03	Amidinocamptpthecin-derivate
NO981495D0 (no)	1998-04-02	Phenoxymetylpiperidin-derivater
DE59710430D1 (de)	2003-08-14	Substituierte 4-benzoyl-pyrazole
DK1015447T3 (da)	2002-06-17	Piperidinylmethyloxazolidinonderivat
FI974001A0 (fi)	1997-10-20	Nya metylenbisfosfonsyraderivat
DE59807877D1 (de)	2003-05-15	Substituierte 4-benzoyl-pyrazole
ID24079A (id)	2000-07-06	Aminoheteroksiklilamida tersubstitusi
NO996391D0 (no)	1999-12-22	Angiogenese-inhiberende tiadiazolylpyridazinderivater
FI972138A0 (fi)	1997-05-20	Returtraog i bestrykningsanordning

Legal Events

Date	Code	Title	Description
2005-09-12	MM1K	Lapsed by not paying the annual fees